Skip to main content

Day: March 1, 2024

Form 8.3 – [WINCANTON PLC] – 29 02 2024 – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree WINCANTON PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [LXi REIT PLC] – 29 02 2024 – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LXi REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Boralex posts record net earnings of $115 million for 2023 and increases its financial flexibility, with nearly $550 million in available cash resources and authorized financing1 to support its growth

Highlights Financial resultsSignificant increase in earnings for the fourth quarter and record results achieved in fiscal 2023 overallIncrease is mainly attributable to strong wind farm performance and the commissioning of assets in France, as well as the integration of the wind farms acquired in the United States in late 2022. EBITDA(A)2 of $202 million ($229 million on a Combined1 basis)3 for Q4-2023 and $578 million ($675 million) for fiscal 2023, up 28% (32%) and 15% (22%) from the same periods in 2022. Operating income of $98 million ($119 million) in Q4-2023 and $226 million ($306 million) for fiscal 2023. Net earnings of $58 million in Q4-2023 and $115 million for fiscal 2023, compared to a net loss of $7 million in Q4-2022 and net earnings of $8 million for fiscal 2022.Record $179M of discretionary1 cash flows and improved...

Continue reading

Plug Highlights Year of Strategic Growth and Advancements in Accelerating the Green Hydrogen Economy

LATHAM, N.Y., March 01, 2024 (GLOBE NEWSWIRE) — Today, Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy announced its financial results and operational milestones for the quarter and fiscal year ended December 31, 2023. With a steadfast commitment to advancing the green hydrogen economy, the Company has achieved significant progress in revenue growth, operational efficiency, and strategic investments aimed at promoting global sustainability and energy independence. Commercial and Operational HighlightsOperational Milestones: The successful commissioning and operational status of the Georgia hydrogen plant, which currently operates the largest PEM electrolyzer system in the United States, and the deployment of our first large-scale megawatt (MW) level stationary...

Continue reading

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual forum, being held in West Palm Beach, Florida. Links to each presentation are included below. Michael S. Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated, “We were pleased to present updated data from the ENHANCE trail evaluating patients switching from a current CD20 to BRIUMVI. It was encouraging to see that patients who switched to one-hour BRIUMVI experienced a manageable safety and tolerability profile. We look forward...

Continue reading

Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

Reports fourth quarter 2023 total revenue of $6.3 million, representing 45% growth compared to fourth quarter 2022 Reports 2023 revenue of $22.5 million, representing 31% growth compared to 2022 Delivered 2023 recurring revenue of $13.5 million, representing 23% growth compared to 2022 Provides 2024 revenue guidance of at least $27.0 million, representing at least 20% growth compared to 2023 LOWELL, Mass., March 01, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the fourth quarter and full year ended December 31, 2023. Recent HighlightsStrong fourth quarter 2023 revenue...

Continue reading

Tulikivi Corporation Financial statements release 1–12/2023: Strong profitability in 2023

TULIKIVI CORPORATION  FINANCIAL STATEMENTS RELEASE  1 MARCH 2024 AT 13.00 EET – The Tulikivi Group’s net sales were EUR 9.9 million (EUR 13.8 million, 10–12/2022) in the fourth quarter and EUR 45.3 million (EUR 44.3 million, 1–12/2022) in the review period.– The Tulikivi Group’s operating profit was EUR 0.6 (1.5) million in the fourth quarter and EUR 5.5 (4.7) million in the review period.– The Tulikivi Group’s profit before taxes was EUR 0.5 million (1.5 million) in the fourth quarter and EUR 4.9 (4.1) million in the review period.– The equity ratio at the end of the review period was 47.8 per cent (39.0).– Order books stood at EUR 6.8 (17.2) million at the end of the review period.– Good results from product tests of the Suomussalmi talc project– Future outlook: Net sales in 2024 are expected...

Continue reading

NIO Inc. Provides February 2024 Delivery Update

NIO delivered 8,132 vehicles in February 2024 NIO delivered 18,187 vehicles year-to-date in 2024 Cumulative deliveries of NIO vehicles reached 467,781 as of February 29, 2024SHANGHAI, China, March 01, 2024 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced its February 2024 delivery results. NIO delivered 8,132 vehicles in February 2024. The deliveries consisted of 4,765 premium smart electric SUVs, and 3,367 premium smart electric sedans. Cumulative deliveries of NIO vehicles reached 467,781 as of February 29, 2024. About NIO Inc. NIO Inc. is a pioneer and a leading company in the premium smart electric vehicle market. Founded in November 2014, NIO’s mission is to shape a joyful lifestyle. NIO aims...

Continue reading

POTENTIAL NEW BOND ISSUE

INVESTOR NEWS no. 13 – 1 March 2024 DFDS, rated BBB-/Stable by Scope Ratings, intends to issue NOK denominated senior unsecured bonds with expected tenors of 3-5 years in the near future. Danske Bank, Nykredit, and SEB have been mandated to arrange a General Investor Call on Monday 4 March 2024. There is no certainty that the issue of the bonds will be initiated or consummated. The proceeds from the potential bond issue are to be used for general corporate purposes.Contact Karina Deacon, CFO +45 33 42 33 42 Søren Brøndholt Nielsen, IR +45 33 42 33 59 Dennis Kjærsgaard Sørensen, Media +45 42 30 38 47About DFDS We operate a transport network in and around Europe with an annual revenue of DKK 27bn and 13,200 full-time employees. We move goods in trailers by ferry, road & rail, and we offer complementary and related...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.